Skip to main content

Teledermatology: Effects on Patient Referral and No-Show

  • Chapter
  • First Online:
Teledermatology

Part of the book series: Updates in Clinical Dermatology ((UCD))

  • 190 Accesses

Abstract

Referral and no-show rates reflect accessibility and efficiency of a healthcare system. Given the shortage of dermatologists in the US and internationally, optimizing patient referrals and decreasing no-shows are important for resource allocation. Teledermatology presents a potential solution to many current challenges by reducing wait times, need for transportation, time needed for clinic visits, and providing efficient patient triage. Clinics that employ telehealth services have seen a significant reduction in no-show rates, particularly among minority populations, indicating an additional opportunity for addressing healthcare disparities. Furthermore, teledermatology can also be used to provide continued education to referring physicians, leading to decreases in rates of unnecessary referrals. While there continue to be limitations facing teledermatology systems, research has shown that patients tend to be highly satisfied with telehealth with similar clinical outcomes. Further investigations into optimal means of integrating teledermatology with in-person referral and care are necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lowell BA, Froelich CW, Federman DG, Kirsner RS. Dermatology in primary care: prevalence and patient disposition. J Am Acad Dermatol. 2001;45:250–5.

    Article  CAS  PubMed  Google Scholar 

  2. Verhoeven EWM, Kraaimaat FW, Van Weel C, Van De Kerkhof PCM, Duller P, Van Der Valk PGM, Van Den Hoogen HJM, Bor JHJ, Schers HJ, Evers AWM. Skin diseases in family medicine: prevalence and health care use. Ann Fam Med. 2008;6:349.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hsiao JL, Oh DH. The impact of store-and-forward teledermatology on skin cancer diagnosis and treatment. J Am Acad Dermatol. 2008;59:260–7.

    Article  PubMed  Google Scholar 

  4. Reed ME, Huang J, Graetz I, Lee C, Muelly E, Kennedy C, Kim E. Patient characteristics associated with choosing a telemedicine visit vs office visit with the same primary care clinicians. JAMA Netw Open. 2020;3:e205873–3.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Landow SM, Mateus A, Korgavkar K, Nightingale D, Weinstock MA. Teledermatology: key factors associated with reducing face-to-face dermatology visits. J Am Acad Dermatol. 2014;71:570–6.

    Article  PubMed  Google Scholar 

  6. Wang RH, Barbieri JS, Nguyen HP, Stavert R, Forman HP, Bolognia JL, Kovarik CL. Clinical effectiveness and cost-effectiveness of teledermatology: where are we now, and what are the barriers to adoption? J Am Acad Dermatol. 2020;83:299–307.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Eminović N, Witkamp L, Ravelli ACJ, Bos JD, Van Den Akker TW, Bousema MT, Henquet CJM, Koopman RJJ, Zeegelaar JE, Wyatt JC. Potential effect of patient-assisted teledermatology on outpatient referral rates. J Telemed Telecare. 2003;9:321–7.

    Article  PubMed  Google Scholar 

  8. Loh CH, Chong Tam SY, Oh CC. Teledermatology in the COVID-19 pandemic: a systematic review. JAAD Int. 2021;5:54–64.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Jones R. GP referral to dermatology: which conditions? Br J Healthcare Manag. 2013;18:594–6. https://doi.org/10.12968/bjhc.2012.18.11.594.

    Article  Google Scholar 

  10. Basarab T, Munn SE, Jones RR. Diagnostic accuracy and appropriateness of general practitioner referrals to a dermatology out-patient clinic. Br J Dermatol. 1996;135:70–3.

    Article  CAS  PubMed  Google Scholar 

  11. Hill VA, Wong E, Hart CJ General Practitioner referral guidelines for dermatology: do they improve the quality of referrals?

    Google Scholar 

  12. Andrees V, Klein TM, Augustin M, Otten M. Live interactive teledermatology compared to in-person care—a systematic review. J Eur Acad Dermatol Venereol. 2020;34:733–45.

    Article  CAS  PubMed  Google Scholar 

  13. Warshaw EM, Hillman YJ, Greer NL, Hagel EM, MacDonald R, Rutks IR, Wilt TJ. Teledermatology for diagnosis and management of skin conditions: a systematic review. J Am Acad Dermatol. 2011;64:759–772.e21.

    Article  PubMed  Google Scholar 

  14. Wootton R, Loane MA, Bloomer SE, Corbett R, Eedy DJ, Hicks N, Lotery HE, Mathews C, Paisley J, Steele K. Multicentre randomised control trial comparing real time teledermatology with conventional outpatient dermatological care: societal cost-benefit analysis. BMJ. 2000;320:1252–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Saffle JR, Edelman L, Theurer L, Morris SE, Cochran A. Telemedicine evaluation of acute burns is accurate and cost-effective. J Trauma. 2009;67:358–65.

    PubMed  Google Scholar 

  16. Pak H, Triplett CA, Lindquist JH, Grambow SC, Whited JD. Store-and-forward teledermatology results in similar clinical outcomes to conventional clinic-based care. J Telemed Telecare. 2007;13:26–30.

    Article  PubMed  Google Scholar 

  17. Whited JD, Hall RP, Foy ME, Marbrey LE, Grambow SC, Dudley TK, Datta S, Simel DL, Oddone EZ. Teledermatology’s impact on time to intervention among referrals to a dermatology consult service. Telemed J E Health. 2004;8:313–21. https://home.liebertpub.com/tmj

    Article  Google Scholar 

  18. Dobry A, Begaj T, Mengistu K, et al. Implementation and impact of a store-and-forward teledermatology platform in an Urban Academic Safety-Net Health Care System. Telemed J E Health. 2021;27(3):308–315. https://doi.org/10.1089/tmj.2020.0069.

  19. Eminović N, De Keizer NF, Wyatt JC, Ter Riet G, Peek N, Van Weert HC, Bruijnzeel-Koomen CA, Bindels PJE. Teledermatologic consultation and reduction in referrals to dermatologists: a cluster randomized controlled trial. Arch Dermatol. 2009;145:558–64.

    Article  PubMed  Google Scholar 

  20. Wang RF, Trinidad J, Lawrence J, et al. Improved patient access and outcomes with the integration of an eConsult program (teledermatology) within a large academic medical center. J Am Acad Dermatol. 2020;83:1633–8.

    Article  PubMed  Google Scholar 

  21. Adepoju OE, Chae M, Ojinnaka CO, Shetty S, Angelocci T. Utilization gaps during the COVID-19 pandemic: racial and ethnic disparities in telemedicine uptake in federally qualified health center clinics. J Gen Intern Med. 2022;37:1191–7.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Marbouh D, Khaleel I, Al Shanqiti K, Al Tamimi M, Simsekler MCE, Ellahham S, Alibazoglu D, Alibazoglu H. Evaluating the impact of patient no-shows on service quality. Risk Manag Health Policy. 2020;13:509–17.

    Article  Google Scholar 

  23. Berg BP, Murr M, Chermak D, Woodall J, Pignone M, Sandler RS, Denton BT. Estimating the cost of no-shows and evaluating the effects of mitigation strategies. Med Decis Mak. 2013;33:976–85.

    Article  Google Scholar 

  24. Brown DN, Shields BE, Shrivastava S, Welsh K, Mir A, Wan J, Hynan LS, Arkin L, Kovarik C, Chong BF. A cross-sectional study of no-show rates and factors contributing to nonattendance at 3 academic pediatric dermatology centers in the United States. J Am Acad Dermatol. 2022;86:1169–72.

    Article  PubMed  Google Scholar 

  25. Chaudhry SB, Siegfried E, Sheikh UA, Simonetta C, Butala N, Armbrecht E. Improving nonattendance rates among pediatric patients with medicaid or private insurance. J Am Acad Dermatol. 2019;81:412–6.

    Article  PubMed  Google Scholar 

  26. Syed ST, Gerber BS, Sharp LK. Traveling towards disease: transportation barriers to health care access. J Community Health. 2013;38:976–93.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Franciosi EB, Tan AJ, Kassamali B, O’Connor DM, Rashighi M, LaChance AH. Understanding the impact of teledermatology on no-show rates and health care accessibility: a retrospective chart review. J Am Acad Dermatol. 2021;84:769–71.

    Article  CAS  PubMed  Google Scholar 

  28. Cline A, Gao JC, Berk-Krauss J, et al. Sustained reduction in no-show rate with the integration of teledermatology in a federally qualified health center. J Am Acad Dermatol. 2021;85:e299–301.

    Article  PubMed  Google Scholar 

  29. Cline A, Jacobs AK, Fonseca M, Marmon S. The impact of telemedicine on no-show rates in pediatric dermatology: a multicenter retrospective analysis of safety-net clinics. J Am Acad Dermatol. 2022;86:e235–7.

    Article  PubMed  Google Scholar 

  30. Van Houten L, Deegan K, Siemer M, Walsh S. A telehealth initiative to decrease no-show rates in a pediatric asthma mobile clinic. J Pediatr Nurs. 2021;59:143–50.

    Article  PubMed  Google Scholar 

  31. Drerup B, Espenschied J, Wiedemer J, Hamilton L. Reduced no-show rates and sustained patient satisfaction of telehealth during the COVID-19 pandemic. Telemed J E Health. 2021;27:1409–15.

    Article  PubMed  Google Scholar 

  32. Policy changes during COVID-19 | Telehealth.HHS.gov. https://telehealth.hhs.gov/providers/policy-changes-during-the-covid-19-public-health-emergency/. Accessed 31 May 2022.

  33. Naka F, Lu J, Porto A, Villagra J, Wu ZH, Anderson D. Impact of dermatology eConsults on access to care and skin cancer screening in underserved populations: a model for teledermatology services in community health centers. J Am Acad Dermatol. 2018;78:293–302.

    Article  CAS  PubMed  Google Scholar 

  34. Calafiore R, Khan A, Anderson D, Wu ZH, Lu J. Impact of dermoscopy-aided pediatric teledermatology program on the accessibility and efficiency of dermatology care at community health centers. J Telemed Telecare. 2021; https://doi.org/10.1177/1357633X211068275.

  35. Phadke NA, del Carmen MG, Goldstein SA, Vagle J, Hidrue MK, Botti ES, Wasfy JH. Trends in ambulatory electronic consultations during the COVID-19 pandemic. J Gen Intern Med. 2020;35:3117–9.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Su MY, Das S. Expansion of asynchronous teledermatology during the COVID-19 pandemic. J Am Acad Dermatol. 2020;83:e471–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Ford JA, Pereira A. Does teledermatology reduces secondary care referrals and is it acceptable to patients and doctors?: a service evaluation. J Eval Clin Pract. 2015;21:710–6.

    Article  PubMed  Google Scholar 

  38. Jiang SW, Flynn MS, Kwock JT, Nicholas MW. Store-and-forward images in teledermatology: narrative literature review. JMIR Dermatol. 2022;5(3):e37517.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Viola KV, Tolpinrud WL, Gross CP, Kirsner RS, Imaeda S, Federman DG. Outcomes of referral to dermatology for suspicious lesions: implications for teledermatology. Arch Dermatol. 2011;147:556–60.

    Article  PubMed  Google Scholar 

  40. Eberly LA, Kallan MJ, Julien HM, et al. Patient characteristics associated with telemedicine access for primary and specialty ambulatory care during the COVID-19 pandemic. JAMA Netw Open. 2020;3(12):e2031640. https://doi.org/10.1001/JAMANETWORKOPEN.2020.31640.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Ryan C, Lewis J. Computer and Internet Use in the United States: 2015. In: US Census Bur. 2017. https://www.census.gov/library/publications/2017/acs/acs-37.html. Accessed 23 June 2022.

  42. Trends Child. Home computer access and internet use. 2018. https://www.childtrends.org/indicators/home-computer-access. Accessed 23 June 2022.

  43. Chang JE, Lai AY, Gupta A, Nguyen AM, Berry CA, Shelley DR. Rapid transition to telehealth and the digital divide: implications for primary care access and equity in a post-COVID era. Milbank Q. 2021;99:340–68.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Lee MS, Ray KN, Mehrotra A, Giboney P, Yee HF, Barnett ML. Primary care practitioners’ perceptions of electronic consult systems: a qualitative analysis. JAMA Intern Med. 2018;178:782–9.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Lee MS, Nambudiri VE. Electronic consultations (eConsults) for safe and equitable coordination of virtual outpatient specialty care. Appl Clin Inform. 2020;11:821–4.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Kim Y, Chen AH, Keith E, Yee HF, Kushel MB. Not perfect, but better: primary care providers’ experiences with electronic referrals in a safety net health system. J Gen Intern Med. 2009;24:614–9.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Kazi R, Evankovich MR, Liu R, Liu A, Moorhead A, Ferris LK, Falo LD, English JC. Utilization of asynchronous and synchronous teledermatology in a large health care system during the COVID-19 pandemic. Telemed J E Health. 2021;27:771–7.

    Article  CAS  PubMed  Google Scholar 

  48. Kwok J, Olayiwola JN, Knox M, Murphy EJ, Tuot DS. Electronic consultation system demonstrates educational benefit for primary care providers. J Telemed Telecare. 2018;24:465–72.

    Article  PubMed  Google Scholar 

  49. Shi Q, Castillo F, Viswanathan K, Kupferman F, MacDermid JC. Facilitators and Barriers to Access to Pediatric Medical Services in a Community Hospital. J Prim Care Community Health. 2020; https://doi.org/10.1177/2150132720904518.

  50. Malviya N, Albrecht J, Amerson E, Colven R, Hsu S, Maurer T, McLellan B, Pomeranz M, Chong BF. Assessment of dermatology clinic resources at safety-net hospitals: results from a national survey. J Am Acad Dermatol. 2017;77:977–978.e2.

    Article  PubMed  Google Scholar 

  51. Hadeler E, Prose N, Floyd LP. Teledermatology: how it is impacting the underserved. Pediatr Dermatol. 2021;38:1597–600.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The article was supported in part by the Office of Scholarly Engagement, Harvard Medical School.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vinod E. Nambudiri .

Editor information

Editors and Affiliations

Ethics declarations

None declared.

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pan, C.X., Malik, R., Nambudiri, V.E. (2023). Teledermatology: Effects on Patient Referral and No-Show. In: English III, J.C. (eds) Teledermatology. Updates in Clinical Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-031-27276-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-27276-9_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-27275-2

  • Online ISBN: 978-3-031-27276-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics